AI brain scans could revolutionize MS care

NCT ID NCT07032246

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: icometrix Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether using an AI tool to analyze brain MRIs helps doctors spot signs of multiple sclerosis (MS) activity more accurately. About 750 people with MS or early warning signs will be split into two groups: one where doctors use the AI tool, and one where they rely on standard MRI reports. The goal is to see if AI leads to better treatment decisions and fewer MS flare-ups over two years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis Nerve Degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ASST Papa Giovanni XXIII Bergamo

    Bergamo, Italy

  • Casa di Cura Igea

    Milan, Italy

  • Charité - Universitätsmedizin Berlin

    Berlin, State of Berlin, 131256, Germany

  • General University Hospital Prague

    Prague, Prague, 2 128 00, Czechia

  • Katholisches Klinikum Bochum - St. Joseph-Hospital

    Bochum, North Rhine-Westphalia, 44791, Germany

  • Technische Universität Dresden

    Dresden, Saxony, 01062, Germany